Aortic & peripheral vascular disease

Revascularization of Asymptomatic Carotid Artery Stenosis: Cognitive Results of the CREST-2 Randomized Trials

JAMAPublished Secondary analysis of the CREST-2 randomised trials

Authors' conclusion

In patients with severe asymptomatic carotid artery stenosis, revascularization with either CAS or CEA plus IMM, compared with IMM alone, did not significantly improve cognitive function at up to 4 years of follow-up.

Study context

Population
Patients aged ≥35 years with ≥70% asymptomatic carotid stenosis, US2,165 (91.5%) in cognitive assessments
Participants
2,366 patients
Comparison
Carotid revascularization + IMM vs IMM alone
  • CAS + IMMn = 529
  • IMM alone (CAS trial)n = 549reference
  • CEA + IMMn = 543
  • IMM alone (CEA trial)n = 544reference
Primary endpoint
Fully adjusted composite cognitive z score (5 tests; MCID 0.50 SD)
Follow-up
Up to 4 years
Methodological detailsprespecified cognitive secondary outcomes, 2 parallel trials, blinded central telephone assessment, 146 clinical sites, 4954 test batteries after baseline; mean follow-up 2.24 (SD, 1.09) years
  • Prespecified cognitive secondary outcomes
  • 2 parallel trials
  • Blinded central telephone assessment
  • 146 clinical sites
  • 4954 test batteries after baseline; mean follow-up 2.24 (SD, 1.09) years

Primary result

As reported in the abstract

Fully adjusted composite z score

CAS + IMM vs IMM alone (CAS trial)

CAS + IMM

0.22

95% CI 0.13–0.30

IMM alone (CAS trial)

0.18

95% CI 0.09–0.27

Estimate (95% CI)
Between-group differenceCAS trial
0.03(−0.09 to 0.15)

CEA + IMM vs IMM alone (CEA trial)

CEA + IMM

0.25

95% CI 0.17–0.33

IMM alone (CEA trial)

0.23

95% CI 0.15–0.32

Estimate (95% CI)
Between-group differenceCEA trial
0.02(−0.09 to 0.14)

Secondary outcomes

Individual cognitive tests

No significant differences between revascularization + medical management vs IMM alone for any individual test

Original publication

Revascularization of Asymptomatic Carotid Artery Stenosis: Cognitive Results of the CREST-2 Randomized Trials. JAMA. Published 16 September 2026. doi:10.1001/jama.2026.14703

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.